Business Wire

NGINX Simplifies the Journey to Microservices

Del

NGINX, Inc., the company based on the popular open source project and offering a suite of technologies designed to develop and deliver modern applications, today announced new capabilities and major enhancements to its Application Platform – an integrated suite of software technologies that simplify the adoption and deployment of microservices.

Enterprise adoption of microservices has reached a tipping point. More than half of companies in a recent survey indicated they deployed microservices for at least one application, and 26% are doing so in production.* Companies are looking to microservices as a modern application architecture to support digital business efforts. However, the transition to microservices is complex and requires enterprises to balance development and delivery across a mix of legacy, monolithic applications and newer, open-sourced based microservices environments.

“Digital transformation makes application modernization imperative for enterprises. Most popular, modern apps are created by cloud-native companies using predominantly open source technologies,” says Gus Robertson, CEO, NGINX. “However, enterprises struggle to implement these same technologies to create compelling customer experiences. To cross this digital divide, enterprises must adopt a microservices architecture that complements their legacy applications. We believe NGINX has the technology to accelerate their journey into microservices.”

NGINX is one of the most ubiquitous software technologies for modern application architectures. More than 11 million new domains launch on NGINX open source each month, an average of 4 every second. Users have pulled a billion NGINX instances from the Docker Store, including over a million pulls of the NGINX Kubernetes Ingress controller. With this footprint, NGINX has established a leadership position in enterprises adoption of microservices. More than 3 million NGINX instances and 250 customers are deployed in production microservices environments.

Simplifying Enterprise Application Architectures
NGINX's lightweight technologies provide a scalable data and control plane that deliver applications across bare metal, VM, container, and public cloud infrastructures. The NGINX Application Platform collapses ten disparate functions into a single, integrated solution: web server, application server, load balancer, reverse proxy, caching, web application firewall, API gateway, ingress controller, sidecar proxy, and service mesh controller. NGINX eliminates the complexity of separate tools, accelerating microservices adoption and freeing up resources to focus on app development instead of infrastructure management.

Capabilities to Further Accelerate Microservices Adoption
With today’s announcement, the NGINX Application Platform capabilities extends to include:

  • New control-plane solution to manage both legacy and microservices apps. NGINX Controller R1 (available Q2, 2018) introduces new monitoring dashboards, alerting, and management of NGINX software. The Controller architecture is extensible and designed to integrate additional control-plane solutions like Istio, eliminating the need for enterprises to deploy multiple frameworks to manage a service mesh.
  • New data-plane features to simplify the microservices application stack. NGINX Plus R15 (available April 10, 2018) builds on new HTTP/2, gRPC, and JavaScript open source features with high-availability clustering and OpenID Connect enhancements. These improve performance and simplify microservices stacks where NGINX runs as a web server, load balancer, API gateway, Kubernetes Ingress controller, or sidecar proxy.
  • New app server to improve performance for modern microservices code. NGINX Unit 1.0 (available April 12, 2018) is a production-ready open source app server. Unit simplifies microservices deployments by supporting multiple languages in a single server, including Go, Perl, Python, PHP, and Ruby. Unit is a developer-friendly, high performance architecture that dynamically configures via an API.

With well-tested products and proven success, NGINX offers enterprises the technologies and expertise at every stage of their journey toward a fully implemented microservices architecture.

About NGINX, Inc.
NGINX, Inc. is the company behind the popular open source project trusted by more than 450 million sites. We offer a suite of technologies for developing and delivering modern applications. The NGINX Application platform allows enterprises undergoing digital transformation to modernize legacy, monolithic applications as well as deliver new, microservices-based applications. Companies like Netflix, Starbucks, and McDonalds rely on NGINX to reduce costs, improve resiliency, and speed innovation.

We are headquartered in San Francisco, with our EMEA head office in Cork, Ireland and APAC head office in Singapore. Learn more at https://www.nginx.com/

*Cited from DZone study

Contact information

PAN Communications for NGINX
Steven MacDonnell
NGINX@pancomm.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+

Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16Pressemelding

HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati

Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30Pressemelding

Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,

Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00Pressemelding

Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward

Overseas Roadshow for the IAPH Guangzhou 2019 World Ports Conference Was Held in London21.9.2018 03:08Pressemelding

Overseas roadshow for the IAPH Guangzhou 2019 World Ports Conference was successfully held in Armourer's Hall, London, UK on September 20th. Ms. Yuan Yue, Deputy Director General of Guangzhou Port Authority, met with over 100 senior representatives from British ports, ship-owners, commodity traders, shipping & service companies, shipping public policy research institutes, and other representatives from the port and shipping industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006031/en/ Speech made by Lord Jeffrey Evans, Chairman of Maritime London (Photo: Business Wire) In her keynote speech, Ms. Yuan Yue said, “Guangzhou is the gateway city of South China and is known as the “Millennium Business Capital” and a popular destination for business and investment. At present, Guangzhou has attracted investors from over 130 countries. Nearly 300 of the world's top 500 companies have businesses and investment in Guangzho

AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS21.9.2018 01:00Pressemelding

AbuDhabi Dubai STOB Series 22 Investment Limited Partnership, hereafter AbuDhabi22, and MINDOL HOLDINGS LIMITED, hereafter MINDOL, listed on the Hong Kong-based Coinsuper exchange (https://www.coinsuper.com) have reached an agreement where AbuDhabi22 will acquire the minimum 33.3 percent holding for the MINDOL cryptocurrency (MIN, https://mindol.net) to be issued by MINDOL, via a tender offer (TOB). Implementation of the TOB will serve to strengthen the strategic partnership with MINDOL. Both companies expect that the AbuDhabi22 bid will greatly exceed any bids made via ordinary exchange channels. With a bid offering at a stable price, the TOB method was chosen for its strategic worth. The MINDOL business vision for 2019 sets a target for its cryptocurrency, from among the more than 2,000 types of cryptocurrencies currently available, to have a top-30 market capitalization. As a business that focuses on "the fusion of subculture and blockchain," they will develop an online game that ta